MedTrace Logo

Cross Sectional CFAR HIV/COVID-19 Study

NCT04514016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2021-03-23

No results posted yet for this study

Summary

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Conditions

  • SARS-CoV Infection
  • Covid19

Sponsors & Collaborators

  • Miami Center for AIDS Research (CFAR)

    collaborator UNKNOWN

  • University of Miami

    lead OTHER

Principal Investigators

  • Charles Mitchell, MD · University of Miami

Eligibility

Min Age
3 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-12
Primary Completion
2021-03-17
Completion
2021-03-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04514016 on ClinicalTrials.gov